-
1
-
-
27744561904
-
Clinical aspects of systemic amyloid diseases
-
doi:10. 1016/j.bbapap. 2005.08.014
-
Obici L, Perfetti V, Palladii G, Moratti R, Merlini G (2005) Clinical aspects of systemic amyloid diseases. Biochim Biophys Acta (BBA)-Proteins Proteomics 1753(1):11-22. doi:10. 1016/j.bbapap. 2005.08.014
-
(2005)
Biochim Biophys Acta (BBA)-proteins Proteomics
, vol.1753
, Issue.1
, pp. 11-22
-
-
Obici, L.1
Perfetti, V.2
Palladii, G.3
Moratti, R.4
Merlini, G.5
-
2
-
-
0025936525
-
Secondary systemic amyloidosis: Response and survival in 64 patients
-
doi:10. 1097/00005792-199107000-00002
-
Gertz MA, Kyle RA (1991) Secondary systemic amyloidosis: response and survival in 64 patients. Medicine 70:246-256. doi:10. 1097/00005792-199107000- 00002
-
(1991)
Medicine
, vol.70
, pp. 246-256
-
-
Ma, G.1
Kyle, R.A.2
-
3
-
-
0028087628
-
Clinical and therapeutic aspects of aa amyloidosis
-
doi:10. 1016/S0950-3579(05) 80121-9
-
Hazenberg BP, van Rijswijk MH (1994) Clinical and therapeutic aspects of AA amyloidosis. Baillieres Clin Rheumatol 8:661-690. doi:10. 1016/S0950-3579(05) 80121-9
-
(1994)
Baillieres Clin Rheumatol
, vol.8
, pp. 661-690
-
-
Hazenberg, B.P.1
Van Rijswijk, M.H.2
-
4
-
-
1842866229
-
Clinical and genetic aspects of the hereditary periodic fever syndromes
-
doi:10. 1093/rheumatology/keh157
-
Grateau G (2004) Clinical and genetic aspects of the hereditary periodic fever syndromes. Rheumatology 43:410-415. doi:10. 1093/rheumatology/keh157
-
(2004)
Rheumatology
, vol.43
, pp. 410-415
-
-
Grateau, G.1
-
5
-
-
4444231190
-
First report of systemic reactive (aa) amyloidosis in a patient with the hyperimmunoglobulinemia d with periodic fever syndrome
-
doi:10. 1002/art. 20490
-
Obici L, Manno C, Onetti Muda A, Picco P, D'Osualdo A, Paladini G, Avanzini MA, Torres D, Marciano S, Merlini G (2004) First report of systemic reactive (AA) amyloidosis in a patient with the hyperimmunoglobulinemia D with periodic fever syndrome. Arthritis Rheum 50:2966-2969. doi:10. 1002/art. 20490
-
(2004)
Arthritis Rheum
, vol.50
, pp. 2966-2969
-
-
Obici, L.1
Manno, C.2
Onetti Muda, A.3
Picco, P.4
D'Osualdo, A.5
Paladini, G.6
Avanzini, M.A.7
Torres, D.8
Marciano, S.9
Merlini, G.10
-
6
-
-
0036176146
-
Pathology, diagnosis and pathogenesis of aa amyloidosis
-
doi:10. 1007/s00428-001-0582-9
-
Rocken C, Shakespeare A (2002) Pathology, diagnosis and pathogenesis of AA amyloidosis. Virchows Arch 440:111-122. doi:10. 1007/s00428-001-0582-9
-
(2002)
Virchows Arch
, vol.440
, pp. 111-122
-
-
Rocken, C.1
Shakespeare, A.2
-
7
-
-
0032918632
-
Serum amyloid a (saa). A concise review of biology, assay methods and clinical usefulness
-
doi:10. 1515/CCLM. 1999.063
-
Yamada T (1999) Serum amyloid A (SAA). A concise review of biology, assay methods and clinical usefulness. Clin Chem Lab Med 37:381-388. doi:10. 1515/CCLM. 1999.063
-
(1999)
Clin Chem Lab Med
, vol.37
, pp. 381-388
-
-
Yamada, T.1
-
8
-
-
0033548474
-
The heparin/heparan sulfate-binding site on apo-serum amyloid a: Implications for the therapeutic intervention of amyloidosis
-
doi:10. 1074/jbc.274.11. 7172
-
Ancsin JB, Kisilevsky R (1999) The heparin/heparan sulfate-binding site on apo-serum amyloid A: implications for the therapeutic intervention of amyloidosis. J Biol Chem 274:7172-7181. doi:10. 1074/jbc.274.11. 7172
-
(1999)
J Biol Chem
, vol.274
, pp. 7172-7181
-
-
Ancsin, J.B.1
Kisilevsky, R.2
-
9
-
-
9444263075
-
Amyloidogenesis recapitulated in cell culture. A peptide inhibitor provides direct evidence for the role of heparan sulfate and suggests a new treatment strategy
-
Elimova E, Kisilevsky R, Szarek WA, Ancsin JB (2004) Amyloidogenesis recapitulated in cell culture. A peptide inhibitor provides direct evidence for the role of heparan sulfate and suggests a new treatment strategy. FASEB J 18:1749-1751
-
(2004)
FASEB J
, vol.18
, pp. 1749-1751
-
-
Elimova, E.1
Kisilevsky, R.2
Szarek, W.A.3
Ancsin, J.B.4
-
10
-
-
18144377807
-
In vivo fragmentation of heparan sulfate by heparanase overex-pression renders mice resistant to amyloid protein a amyloidosis
-
doi: 10. 1073/pnas.0502287102
-
Li JP, Galvis ML, Gong F, Zhang X, Zcharia E, Metzger S, Vlodavsky I, Kisilevsky R, Lindahl U (2005) In vivo fragmentation of heparan sulfate by heparanase overex-pression renders mice resistant to amyloid protein A amyloidosis. Proc Natl Acad Sci USA 102: 6473-6477. doi: 10. 1073/pnas.0502287102
-
(2005)
Proc Natl Acad Sci USA
, vol.102
, pp. 6473-6477
-
-
Li, J.P.1
Galvis, M.L.2
Gong, F.3
Zhang, X.4
Zcharia, E.5
Metzger, S.6
Vlodavsky, I.7
Kisilevsky, R.8
Lindahl, U.9
-
11
-
-
0036860278
-
Serum amyloid p component scintigraphy for diagnosis and monitoring amyloidosis
-
doi:10. 1097/00041552-200211000-00013
-
Hawkins PN (2002) Serum amyloid P component scintigraphy for diagnosis and monitoring amyloidosis. Curr Opin Nephrol Hypertens 11:649-655. doi:10. 1097/00041552-200211000-00013
-
(2002)
Curr Opin Nephrol Hypertens
, vol.11
, pp. 649-655
-
-
Hawkins, P.N.1
-
12
-
-
77954563049
-
A one-center experience with pediatric percutaneous renal biopsy and histopathology in ankara, turkey
-
doi: 10. 1007/s11255-008-9433-9
-
Demircin G, Deliba A, Bek K et al (2008) A one-center experience with pediatric percutaneous renal biopsy and histopathology in Ankara, Turkey. Int Urol Nephrol. doi: 10. 1007/s11255-008-9433-9
-
(2008)
Int Urol Nephrol
-
-
Demircin, G.1
Deliba, A.2
Bek, K.3
-
13
-
-
0033895284
-
Presentation, survival and prognostic markers in aa amyloidosis
-
Joss N, McLaughlin K, Simpson K, Boulton-Jones JM (2000) Presentation, survival and prognostic markers in AA amyloidosis. Q J Med 93:535-542
-
(2000)
Q J Med
, vol.93
, pp. 535-542
-
-
Joss, N.1
McLaughlin, K.2
Simpson, K.3
Boulton-Jones, J.M.4
-
14
-
-
23244448608
-
Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (al): A consensus opinion from the 10th international symposium on amyloid and amyloidosis
-
doi:10. 1002/ ajh. 20381
-
Gertz MA, Comenzo R, Falk RH, Fermand JP, Hazenberg BP, Hawkins PN, Merlini G, Moreau P, Ronco P, Sanchorawala V, Sezer O, Salomon A, Grateau G (2005) Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th international symposium on amyloid and amyloidosis. Am J Hematol 79:319-328. doi:10. 1002/ ajh. 20381
-
(2005)
Am J Hematol
, vol.79
, pp. 319-328
-
-
Ma, G.1
Comenzo, R.2
Falk, R.H.3
Fermand, J.P.4
Hazenberg, B.P.5
Hawkins, P.N.6
Merlini, G.7
Moreau, P.8
Ronco, P.9
Sanchorawala, V.10
Sezer, O.11
Salomon, A.12
Grateau, G.13
-
15
-
-
11244272941
-
The czech registry of renal biopsies. Occurrence of renal diseases in the years 1994-2000
-
doi:10. 1093/ndt/gfh521
-
Rychlik I, Jancova E, Tesar V et al (2004) The Czech registry of renal biopsies. Occurrence of renal diseases in the years 1994-2000. Nephrol Dial Transplant 19:3040-3049. doi:10. 1093/ndt/gfh521
-
(2004)
Nephrol Dial Transplant
, vol.19
, pp. 3040-3049
-
-
Rychlik, I.1
Jancova, E.2
Tesar, V.3
-
16
-
-
0029657780
-
Shift in the incidence of rheumatoid arthritis towards elderly patients in finland during 1875-1990
-
Kaipiainen-Sepannen O, Aho K, Isomaki H, Laakso M (1996) Shift in the incidence of rheumatoid arthritis towards elderly patients in Finland during 1875-1990. Clin Exp Rheumatol 14:537-542
-
(1996)
Clin Exp Rheumatol
, vol.14
, pp. 537-542
-
-
Kaipiainen-Sepannen, O.1
Aho, K.2
Isomaki, H.3
Laakso, M.4
-
17
-
-
0033867112
-
Where has secondary amyloidosis gone?
-
doi:10. 1136/ard.59.8.577
-
Hazenberg BPC, van Rijswijk MH (2000) Where has secondary amyloidosis gone? Ann Rheum Dis 59:577-579. doi:10. 1136/ard.59.8.577
-
(2000)
Ann Rheum Dis
, vol.59
, pp. 577-579
-
-
Bpc, H.1
Van Rijswijk, M.H.2
-
18
-
-
34447553709
-
Renal involvement in systemic amyloidosis-an italian retrospective study on epidemiological and clinical data at diagnosis
-
doi:10. 1093/ndt/gfm041
-
Bergesio F, Ciciani AM, Santostefano M, Brugnano R, Manganaro M, Palladini G, Di Palma AM, Gallo M, Tosi PL, Salvadori M (2007) Renal involvement in systemic amyloidosis-an Italian retrospective study on epidemiological and clinical data at diagnosis. Nephrol Dial Transplant 22:1608-1618. doi:10. 1093/ndt/gfm041
-
(2007)
Nephrol Dial Transplant
, vol.22
, pp. 1608-1618
-
-
Bergesio, F.1
Ciciani, A.M.2
Santostefano, M.3
Brugnano, R.4
Manganaro, M.5
G, I.D.P.6
Palma, A.M.7
Gallo, M.8
Tosi, P.L.9
Salvadori, M.10
-
19
-
-
47349109629
-
No improvement in survival of patients with amyloidosis associated with inflammatory rheumatic diseases-data from the finnish national registry for kidney diseases
-
Immonen K, Finne P, Hakala M, Kautiainen H, Pettersson T, Grönhagen-Riska C (2008) No improvement in survival of patients with amyloidosis associated with inflammatory rheumatic diseases-Data from the Finnish national registry for kidney diseases. J Rheumatol 35:7
-
(2008)
J Rheumatol
, vol.35
, pp. 7
-
-
Immonen, K.1
Finne, P.2
Hakala, M.3
Kautiainen, H.4
Pettersson, T.5
Grönhagen-Riska, C.6
-
20
-
-
0041310012
-
Current therapeutic possibilities in primary and secondary amyloidosis and our experience with 31 patients
-
doi:10. 1093/ndt/gfg1043
-
Rysava R, Merta M, Spicka I, Tesar V (2003) Current therapeutic possibilities in primary and secondary amyloidosis and our experience with 31 patients. Nephrol Dial Transplant 18(5):38-40. doi:10. 1093/ndt/gfg1043
-
(2003)
Nephrol Dial Transplant 18(5)
, pp. 38-40
-
-
Rysava, R.1
Merta, M.2
Spicka, I.3
Tesar, V.4
-
21
-
-
0035822274
-
Amyloid load and clinical outcome in aa amyloidosis in relation to circulating concentration of serum amyloid a protein
-
doi:10. 1016/ S0140-6736(00)05252-1
-
Gillmore JD, Lovat LB, Persey MR, Pepys MB, Hawkins PN (2001) Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein. Lancet 358:24-29. doi:10. 1016/ S0140-6736(00)05252-1
-
(2001)
Lancet
, vol.358
, pp. 24-29
-
-
Gillmore, J.D.1
Lovat, L.B.2
Persey, M.R.3
Pepys, M.B.4
Hawkins, P.N.5
|